AllianceBernstein’s Monte Rosa Therapeutics GLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$873K Sell
55,700
-7,780
-12% -$149K ﹤0.01% 2390
2025
Q4
$995K Hold
63,480
﹤0.01% 2342
2025
Q3
$470K Hold
63,480
﹤0.01% 2712
2025
Q2
$286K Buy
63,480
+28,340
+81% +$126K ﹤0.01% 2937
2025
Q1
$163K Hold
35,140
﹤0.01% 2974
2024
Q4
$244K Hold
35,140
﹤0.01% 2970
2024
Q3
$186K Buy
35,140
+2,360
+7% +$11.9K ﹤0.01% 3051
2024
Q2
$123K Buy
32,780
+9,210
+39% +$47K ﹤0.01% 3096
2024
Q1
$166K Hold
23,570
﹤0.01% 2959
2023
Q4
$133K Hold
23,570
﹤0.01% 3030
2023
Q3
$113K Buy
23,570
+1,720
+8% +$11.1K ﹤0.01% 3047
2023
Q2
$150K Buy
21,850
+7,650
+54% +$49.5K ﹤0.01% 3032
2023
Q1
$111K Buy
14,200
+1,800
+15% +$12.5K ﹤0.01% 3017
2022
Q4
$94.4K Buy
+12,400
New +$103K ﹤0.01% 3117
2022
Q2
Sell
-81,302
Closed -$1.14M 3310
2022
Q1
$1.14M Sell
81,302
-8,867
-10% -$123K ﹤0.01% 2376
2021
Q4
$1.84M Buy
90,169
+5,722
+7% +$120K ﹤0.01% 2193
2021
Q3
$1.88M Sell
84,447
-54,648
-39% -$1.57M ﹤0.01% 2205
2021
Q2
$3.16M Buy
+139,095
New +$2.83M ﹤0.01% 1902

Other funds holding GLUE